BRCA1 and breast cancer: Despite these findings, some studies presented contrasting results; for instance, Kauff et al. (2008) [25] and Mavaddat et al. (2020) [29] reported that RRO did not significantly reduce the risk of ER-negative BC and BC risk in BRCA1 carriers, respectively.